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Abstract
Protamine has been widely used as a pharmaceutical product and natural food preservative. However, few studies have been conducted to assess 
the beneficial function of dietary protamine. This study examined the effects of dietary salmon protamine on serum and liver lipid levels and the 
expression levels of genes encoding proteins involved in lipid homeostasis in the liver of rats. Groups of male Wistar rats were fed AIN93G diet
containing 2% or 5% protamine. After 4 weeks of feeding these diets, markedly decreased serum and liver cholesterol (CHOL) and triacylglycerol
levels were noted. Increased activity of liver carnitine palmitoyltransferase-2 and acyl-CoA oxidase, which are key enzymes of fatty acid β-oxidation
in the mitochondria and peroxisomes, was found in rats fed on protamine. Furthermore, rats fed protamine showed enhanced fecal excretion of
CHOL and bile acid and increased liver mRNA expression levels of ATP-binding cassette (ABC) G5 and ABCG8, which form heterodimers and 
play a major role in the secretion of CHOL into bile. The decrease in triacylglycerol levels in protamine-fed rats was due to the enhancement
of liver β-oxidation. Furthermore, rats fed protamine exhibited decreased CHOL levels through the suppression of CHOL and bile acid absorption 
and the enhancement of CHOL secretion into bile. These results suggest that dietary protamine has beneficial effects that may aid in the prevention
of lifestyle-related diseases such as hyperlipidemia and atherosclerosis.
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Introduction3)
In Western industrialized countries, the incidence of 
lifestyle-related diseases, such as atherosclerosis, hypertension, 
obesity, and hyperlipidemia, has been increasing in the last few 
decades [1]. Dietary therapy is important and could be considered 
as the first choice treatment or at least as important as medical 
treatment. Epidemiological evidence from Greenland Inuit and 
Japanese fishing villages suggests that eating fish and marine 
animals can prevent coronary heart disease (CHD) [2,3]. Dietary 
studies from many investigators have similarly shown that regular 
fish intake affects several humoral and cellular factors involved 
in CHD and may prevent atherosclerosis, thrombosis, and sudden 
cardiac death [4]. Some researchers have indicated that the 
beneficial effects of fish are attributable to their n-3 polyunsaturated 
fatty acids (PUFA), such as eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) [5]. Many studies have reported 
that EPA and DHA have beneficial effects on the prevention 
of hyperlipidemia and atherosclerosis by decreasing the serum 
triacylglycerol (TG)
  content [6]. However, it is not possible to 
explain these health functions of fish-based foods only in terms 
of EPA and DHA. In fact, general dietary habits include not 
only fish oil but also the fish itself, which provide nutrients such 
as proteins as well as fat [7]. On the other hand, some studies 
have indicated that fish meat protein also influences blood lipid 
contents and stimulates fibrinolysis in experimental animals [8,9]. 
Furthermore, we have previously reported the effects of dietary 
fish protein on serum and liver lipid concentrations in rats [10].
In the past, the potential health functions of fish tissues, except 
for muscle, have attracted little attention. For example, for the 
testes and ovaries, which are considered as edible parts, there 
is only information concerning the high levels of cholesterol 
(CHOL) and nucleic acids. Therefore, we focused on the effect 
of protamine from salmon milt on lipid metabolism. Protamine 
from salmon milt, also called salmine, has a low molecular 
weight of around 4,000-5,000, which plays a role in protecting 
DNA from being damaged. As a pharmaceutical product, protamine 
acts as an antidote to heparin, maintains antihyperglycemic 
effects together with insulin, and also functions to restrict fat 
absorption in the intestine [11]. In addition, protamine has also 
been widely used as a natural food preservative, because 
protamine has a strong antibacterial effect [12]. Previous studies 
showed that protamine strongly inhibited the hydrolysis of 
trioleoylglycerol emulsified with phosphatidylcholine [13] and 
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Components
Diet group
Control ProtL ProtH
α-Corn starch 132 132 132
β-Corn starch 397.5 397.5 397.5
Casein 200 180 150
Salmon protamine* - 20 50
Sucrose 100 100 100
Cellulose 50 50 50
Mineral mixture
† 35 35 35
Vitamin mixture
† 10 10 10
L-Cystine 3 3 3
Choline bitartrate 2.5 2.5 2.5
Soybean oil 70 70 70
Diets  were  prepared  based  on  the  AIN-93G  composition.
*Protamine  purity  of  salmon  protamine  was  83.5%.
†AIN-93G  formula
Table 1. Composition of the experimental diets (g/kg)
Amino acid
Diet group Salomon
protamine Control ProtL ProtH
Arginine 33 108 220 6
Alanine 71 64 53 780
Aspartic acid 27 24 20 ND
Cystine 45 41 34 ND
Glutamic acid 50 45 38 ND
Glycine 84 76 63 32
Histidine 49 45 39 ND
Isoleucine 26 23 20 9
Leucine 60 58 54 ND
Lysine 27 25 22 ND
Methionine 16 18 20 ND
Phenylalanine 100 97 92 ND
Proline 190 171 143 67
Serine 46 48 52 39
Threonine 37 33 28 ND
Tryptophan 63 57 47 ND
Tyrosine 11 10 8 ND
Valine 4 4 3 38
ND, Not detected; ProtL, diet containing 2% protamine; ProtH, diet containing 5% 
protamine
Table 2. Amino acid contents of the experimental diets and salmon protamine
 (g/kg protein)
protamine reduce weight gain and body fat accumulation through 
the inhibition of dietary fat absorption [14]. However, few studies 
have evaluated the beneficial effect of protamine besides the 
inhibition of fat absorption. To examine the effect of dietary 
protamine on lipid metabolism, we evaluated serum and liver 
lipid contents, lipid metabolizing enzyme activities in the liver, 
the excretion of fecal lipid, and the expression mRNA levels 
of CHOL-related enzymes in rats.
Materials and Methods
Materials
Salmon protamine was provided by Asama Chemical Co., Ltd. 
(Tokyo, Japan). AIN-93G vitamin mix, AIN-93G mineral mix, 
α-cornstarch,  β-cornstarch, cellulose, sucrose, and casein were 
purchased from Oriental Yeast Co., Ltd (Tokyo, Japan). 
L-Cystine, choline bitartrate, and soybean oil were purchased 
from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). All 
other chemicals used were of reagent grade.
Animal care and experimental diets
Five-week-old male Wistar rats obtained from Shimizu 
Laboratory Supplies Co., Ltd (Kyoto, Japan) were housed in 
plastic cages in an air-conditioned room (temperature, 20-22℃; 
humidity, 55-65%; lights on, 08:00-20:00 h). After acclimation 
for 3 days with a diet prepared according to that recommended 
by the American Institute of Nutrition (AIN-93G) [15], rats were 
divided randomly into three groups and given free access to water 
and the experimental diet. Table 1 shows the composition of the 
experimental diets prepared according to AIN-93G. Experimental 
diet consumption and body weight were recorded every two days. 
Feces were collected from each group every 24 hours for seven 
days prior to sacrifice. After treatment with the experimental diets 
for 4 weeks, rats were weighed and sacrificed under Nembutal 
(Dainippon Sumitomo Pharma Co., Ltd, Osaka, Japan) anesthesia. 
Rats were not fasted before being sacrificed because food 
deprivation prior to sacrifice leads to a significant down-regulation 
of the genes involved in fatty acid synthesis and CHOL 
metabolism [16]. Blood was collected from the descending aorta, 
and serum was prepared by centrifugation at 1,500 × g for 15 
min and then stored at -80℃ until analysis. Liver and abdominal 
white adipose tissue (WAT) were rapidly removed in their 
entirety and were weighed, rinsed, frozen in liquid nitrogen, and 
kept at -80℃. Aliquots of the liver were taken for mRNA 
expression analysis and stored in RNA-Later Storage Solution 
(Sigma Chemical Co., St. Louis, MO, USA). The experimental 
protocol was reviewed and approved by the Animal Ethics 
Committee of Kansai Medical University and followed the 
“Guide for the Care and Use of Experimental Animals” of the 
Prime Minister’s Office of Japan.
Analysis of experimental diets and salmon protamine amino acid 
composition
The experimental diets and salmon protamine amino acid 
composition was analyzed by high-performance liquid chromatography 
as follows. The samples were hydrolyzed using 6 M HCl. The 
hydrolyzed samples were subjected to HPLC, in which the 
samples were automatically derivatized using o-phthalaldehyde 
and separated on a reversed-phase column (GL Sciences Inertsil 
ODS-3, 5 μm, 250 × 4.6 mm) at 40℃  with 25 mM sodium 
phosphate buffer (pH 7.0) and acetonitrile using a gradient 464 Effect of protamine on rat lipid metabolism
Gene name 5'→3' primer sequence Accession number
GAPDH F:GAAGACACCAGTAGACTCCACGACATA
R:GAAGGTCGGTGTGAACGGATT
NM_017008
LDLR F:CACCCCCTCGTTGAAAACCT
R:CCTTAGCCAGCTCTTCCAGATC
NM_175762
SR-B1 F:GCATTCGGAACAGTGCAACA
R:TCATGAATGGTGCCCACATC
NM_031541
ABCA1 F:CCCGGCGGAGTAGAAAGG
R:AGGGCGATGCAAACAAAGAC
NM_178095
ABCG5 F:CCTCAAGGGCTCCGAGAACT
R:ACCACACTGCCCCATAAGCT
NM_053754
ABCG8 F:GCCATGGACCTGAACTCACA
R:GCTGATGCCAATGACGATGA
NM_130414
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; LDL-R, low density lipoprotein 
receptor; SR-B1, scavenger receptor class B type 1; ABCA1, ATP-binding cassette 
A1; ABCG5, ATP-binding cassette G5; ABCG8, ATP-binding cassette G8; F, forward; 
R,  reverse
Table 3. Sequences of the specific primers used for reverse transcriptase 
polymerase chain reaction analysis
program at a flow rate of 1.0 mL/min. The eluate was monitored 
by fluorescence detection with an excitation wavelength of 340 
nm and emission wavelength of 450 nm. The identification and 
quantitation of each amino acid were carried out using comm-
ercially available authentic standard mixtures and a CR-6A 
Chromatopac integrator (Shimadzu, Kyoto, Japan). Table 2 
summarizes the amino acid composition of each diet and 
protamine.
Analysis of serum and liver lipids
Serum total lipid (TL), phospholipids (PL), TG, CHOL, high 
density lipoprotein-cholesterol (HDL-C), and low density 
lipoprotein-cholesterol (LDL-C) contents were analyzed using an 
Olympus AU5431 automatic analyzer.
The very low density lipoprotein (VLDL) fraction was isolated 
from the fresh serum by ultracentrifugation (Himac CS-100, 
Hitachi Koki Co., Ltd., Tokyo, Japan) at a density of < 1.006 
g/ml after adjustment with NaCl, and then the chylomicron 
fraction was removed because the rats were not fasted before 
sacrifice [17]. Serum VLDL TG and CHOL contents were 
analyzed using enzymatic kits obtained from Wako Pure 
Chemical Industries, Ltd. (Osaka, Japan).
Liver lipids were extracted using a mixture of chloroform: 
methanol:water (1:1:0.9, v/v). The liver TG content was 
determined as follows; liver lipids were dissolved in an equal 
volume of dimethylsulfoxide and then used to determine the TG 
content using an enzymatic assay kit (Triglyceride-E-Test Wako, 
Wako Pure Chemical Industries, Ltd., Osaka, Japan). The liver 
CHOL content was analyzed using a SE-30 column (Shinwa 
Chemical Industries LTD., Kyoto, Japan) with a GC-14B gas 
chromatograph and 5α-cholestane as an internal standard. The 
liver PL content was measured by phosphorus analysis of liver 
lipids, and the liver protein content was determined by the 
method of Lowry et al. [18] using bovine serum albumin as a 
standard.
Preparation of the liver and enzyme activity assay
Liver tissue was homogenized in 10 volumes of a 0.25 M 
sucrose solution containing 1 mM EDTA-2Na in 3 mM Tris-HCl 
buffer (pH 7.4). The homogenate was centrifuged at 500 × g for 
10 min at 4℃. The supernatant was recentrifuged at 9,000 × g 
for 10 min at 4℃ to sediment the mitochondria, and the remaining 
supernatant was collected. Furthermore, the supernatant was 
ultracentrifuged at 105,000 × g for 60 min at 4℃  to give a 
remaining supernatant and a microsome fraction.
Acyl-CoA oxidase (ACO, EC 1.3.3.6) activity was assayed in 
the 500 × g supernatant fraction of the liver homogenate [19]. 
Carnitine palmitoyltransferase-2 (CPT2, EC 2.3.1.21) activity in 
the mitochondrial fraction was assayed as described by Markwell 
et al. [20]. The activities of fatty acid synthase (FAS) [21], 
acetyl-CoA carboxylase (ACC, EC 6.4.1.2) [22], and glucose-6- 
phosphate dehydrogenase (G6PDH, EC 1.1.1.49)
  [23] in the 
105,000 × g supernatant fraction and microsomal phosphatidate 
phosphatase (PAP, EC 3.1.3.4)
  [24] in the microsome fraction 
were assayed spectrophotometrically. The protein content of 
various fractions was determined according to the method of 
Lowry  et al. [18].
Analysis of the fecal lipids and nitrogen
Total bile acid content in the feces was determined as µmoles 
3α-hydroxysteroid based on the molar extinction coefficient of 
NADH at 340 nm, and fecal CHOL content was determined by 
gas-liquid chromatography using a SE-30 column with a GC-14B 
gas chromatograph (Shimadzu, Kyoto, Japan) and 5α-cholestane 
as an internal standard. Fecal fatty acid content was determined 
by the method of van de Kamer et al.
  [25]. Fecal protein content 
was determined by the Kjeldahl method. The apparent digestibility 
of protein was calculated as Apparent digestibility (%) = (Protein 
intake - Fecal protein)/Protein intake × 100.
Analysis of liver mRNA expression
Total RNA was extracted from the liver using an RNeasy Mini 
Kit (Qiagen, Tokyo, Japan) in accordance with the manufacturer’s 
protocol. Then, cDNA was synthesized from total RNA using 
a High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems Japan Ltd., Tokyo, Japan). Real-time quantitative 
polymerase chain reaction (PCR) analysis was performed using 
an automated sequence detection system (ABI Prism 7000; 
Applied Biosystems Japan Ltd., Tokyo, Japan). 3-Hydroxy-3- 
methylglutaryl-CoA reductase (HMGR), cholesterol 7α-hydroxylase 
(CYP7A1), and glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) mRNA expression levels were determined using TaqMan 
Gene Expression Assays (Applied Biosystems Japan Ltd., 
Tokyo, Japan). PCR Primers (HMGR: Rn00565598_m1; CYP7A1: 
Rn00564065_m1; GAPDH: Rn99999916_s1) were purchased Ryota Hosomi et al. 465
Diet group
Control ProtL ProtH
Initial BW (g) 127.1 ± 7.0 129.3 ± 5.3 130.0 ± 7.6
Final BW (g) 312.1 ± 13.2 322.1 ± 13.8 323.6 ± 22.3
BW gain (g/day) 6.6 ± 0.3 6.9 ± 0.4 6.9 ± 0.6
Energy intake (kcal/day) 68.3 ± 5.2 69.7 ± 7.7 71.4 ± 8.0
Food efficiency (g/kcal) 0.096 ± 0.004 0.096 ± 0.006 0.097 ± 0.009
Relative organ weight (g/kg BW)
Liver weight 0.38 ± 0.02 0.69 ± 0.07 0.36 ± 0.04
Epididymal WAT weight 0.15 ± 0.01 0.15 ± 0.03 0.15 ± 0.02
Mensentery WAT weight 0.13 ± 0.03 0.13 ± 0.04 0.13 ± 0.04
Perirenal and retroperitoneal WAT 0.13 ± 0.02 0.14 ± 0.06 0.13 ± 0.03
Total WAT weight* 0.50 ± 0.05 0.51 ± 0.14 0.50 ± 0.10
Data are means±SD (n=7). Values not sharing a common letter are significantly 
different at P < 0.05. Data were analyzed by Tukey-Kramer test. Rats were fed the 
experimental diets for 4 weeks. Food consumption and body weight were recorded 
every  two  days.  The  liver  and  WAT  weights  were  obtained  after  sacrifice.
BW,  body  weight;  WAT,  white  adipose  tissue 
*Total WAT = epididymal WAT + mesentery WAT + perirenal and retroperitoneal WAT
Table 4. Initial body weight, final body weight, body weight gain, energy intake,
energy efficiency ratio, relative liver weight, and various WAT weights of rats 
fed the experimental diets for 4 weeks
Diet group
Control ProtL ProtH
Serum (mg/dl)
TL 218.7 ± 33.5
a 185.9 ± 16.0
b 169.3 ± 15.0
b
TG 35.3 ± 4.5
a 31.3 ± 3.6
a 24.0 ± 4.3
b
CHOL 68.3 ± 12.3
a 62.7 ± 5.8
ab 54.3 ± 9.7
b
PL 95.6 ± 10.6 89.7 ± 18.9 96.6 ± 14.6
HDL-C 58.6 ± 7.6 56.4 ± 7.0 51.4 ± 4.9
LDL-C 7.3 ± 1.1
a 6.9 ± 0.6
a 5.4 ± 0.8
b
VLDL-TG 13.7 ± 1.8
a 6.4 ± 1.9
b 4.2 ± 1.3
b
VLDL-C 1.8 ± 0.3
a 0.7 ± 0.3
b 0.5 ± 0.3
b
Liver (mg/g protein)
TL 378.2 ± 47.5
a 268.4 ± 51.8
b 270.4 ± 23.1
b
TG 215.1 ± 46.4
a 129.4 ± 52.8
b 127.5 ± 22.6
b
CHOL 21.7 ± 3.9
a 13.8 ± 3.6
b 10.1 ± 1.4
b
PL 139.1 ± 23.9 134.7 ± 23.3 124.3 ± 15.6
Data are means±SD (n=7). Values not sharing a common letter are significantly 
different at P < 0.05. Data were analyzed by Tukey-Kramer test. The serum was 
obtained from blood in the portal vein. The serum lipid contents were measured 
using  an  Olympus  AU5431  automatic  analyzer.
TL, total lipid; TG, triacylglycerol; CHOL, cholesterol; PL, phospholipid; HDL-C, high 
density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; VLDL-TG, 
very  low  density  lipoprotein-triacylglycerol;  VLDL-C,  very  low  density  lipoprotein- 
cholesterol 
Table 5. Lipid content in the serum and liver of rats fed the experimental diets
for 4 weeks
from Applied Biosystems (Japan Ltd., Tokyo, Japan). In addition, 
low density lipoprotein receptor (LDLR), scavenger receptor 
class B type 1 (SR-B1), ATP-binding cassette (ABC) A1 
(ABCA1), ABCG5, ABCG8, and GAPDH mRNA expression 
levels were determined using SYBR Green PCR Master Mix 
(Applied Biosystems, Tokyo, Japan). PCR primers (Table 3) for 
LDL-R, SR-B1, ABCA1, ABCG5, ABCG8, and GAPDH were 
designed using Primer Express 3.0 software (Applied Biosystems, 
Tokyo, Japan). The PCR cycling conditions were 50℃ for 2 min 
and 95℃ for 10 min, followed by 40 cycles of 95℃ for 15 
sec and 60℃ for 1 min. The expression level of the housekeeping 
gene GAPDH served as an internal control and was used for 
normalization.
Statistical analysis
Data are presented as means ± SD of seven rats. Statistical 
differences between multiple groups were determined by analysis 
of variance (ANOVA). Statistical comparisons were made using 
the Tukey-Kramer test. Difference were considered significant 
at  P <0 . 0 5 .
Results
Growth parameters and organ weights
Table 4 shows body weight, body weight gain, food intake, 
food efficiency, relative liver, and various WAT weights. There 
were no significant differences in body weight, body weight gain, 
food intake, or food efficiency among the groups. Dietary 
protamine did not affect the growth of rats. In addition, relative 
liver and various WAT weights did not show any differences 
among the groups.
Serum and liver lipid parameters
Table 5 shows the serum lipid and liver lipid contents. The 
serum TL, VLDL-TG, and VLDL-C contents in the low 
protamine (2%; ProtL) and high protamine (5%; ProtH) groups 
were significantly lower than in the control group, and there was 
no difference between the ProtL and ProtH groups. The serum 
TG, CHOL, and LDL-C contents were significantly lower the 
ProtH group compared with the control group. The serum HDL-C 
content in rats fed protamine tended to be lower than in rats 
fed casein, but not to a significant degree. No differences were 
found in serum PL among the groups.
The liver TL, TG, and CHOL contents in rats fed protamine 
were markedly lower than in rats fed casein. Furthermore, there 
was no difference between the ProtL and ProtH groups in the 
liver TL, TG, and CHOL contents. No differences were found 
in liver PL among the groups.
Liver enzyme activity
We assayed the activities of fatty acid β-oxidation and fatty 
acid synthesis related enzymes to investigate the regulatory effect 
of dietary protamine on fatty acid metabolism in the liver (Table 
6). The activity of CPT2, a key enzyme of fatty acid β-oxidation 
in mitochondria, was significantly higher in the ProtH group than 
in the control group. ACO activity, a key enzyme of fatty acid 466 Effect of protamine on rat lipid metabolism
Enzyme
Diet group
Control ProtL ProtH
FAS 3.2 ± 0.6
a 4.0 ± 0.6
ab 4.8 ± 0.8
b
ACC 159.4 ± 20.2 177.2 ± 19.8 169.7 ± 36.0
G6PDH 20.3 ± 4.9
a 16.4 ± 3.0
ab 13.0 ± 5.3
b
PAP 9.3 ± 0.6 8.9 ± 0.9 9.3 ± 0.6
CPT2 7.5 ± 1.0
a 9.0 ± 1.7
ab 9.7 ± 1.6
b
ACO 1.5 ± 0.2
a 2.1 ± 0.1
b 2.2 ± 0.2
b
Data are means ± SD (n = 7). Values not sharing a common letter are significantly 
different at P < 0.05. Data were analyzed by Tukey-Kramer test. The activities of 
enzymes  related  to  the  fatty  acid  metabolism  were  analyzed  by  absorption 
spectrometer.
FAS,  fatty  acid  synthase;  ACC,  acetyl-CoA  carboxylase;  G6PDH,  glucose-6- 
phosphate  dehydrogenase;  PAP,  phosphatidate  phosphatase;  CPT2,  carnitine 
palmitoyl  transferase-2;  ACO,  acyl-CoA  oxidase
Table 6. Activities of enzymes related to the fatty acid metabolic pathways in
the liver of Wistar rats (nmol/min mg protein)
Diet group
Control ProtL ProtH
Fatty acid (mg/day) 40.1 ± 6.5
a 51.7 ± 9.4
a 87.8 ± 12.5
b
Cholesterol (mg/day) 5.8 ± 1.1
a 7.0 ± 1.1
ab 8.1 ± 0.8
b
Bile acid (µmol/day) 3.2 ± 0.8
a 6.0 ± 1.5
b 5.9 ± 0.9
b
Food intake (g/day) 120.8 ± 9.2 118.0 ± 13.6 126.3 ± 14.2
Fecal dry weight (g/day) 11.7 ± 2.2 10.9 ± 2.2 13.7 ± 2.0
Nitrogen (mg/day) 160.6 ± 23.4 179.3 ± 34.9 165.3 ± 27.9
Fecal protein (g/day) 1.0 ± 0.2 1.1 ± 0.2 1.0 ± 0.2
Intake of dietary protein (g/day) 22.6 ± 1.4 21.1 ± 3.1 24.1 ± 2.4
Apparent protein digestibility (%)* 95.6 ± 0.7 94.6 ± 1.2 95.6 ± 1.1
Data are means±SD (n=7). Values not sharing a common letter are significantly 
different  at  P < 0.05.
Feces  were  collected  from  each  group  every  24  hours  for  seven  days  prior  to 
sacrifice.
*Apparent protein digestibility (%) = (intake of dietary protein - fecal protein) / intake 
of  dietary  protein × 100
Table 7. Fecal fatty acid, cholesterol, bile acid, nitrogen contents, and protein 
digestibility in rats fed the experimental diets for 4 weeks
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Fig. 1. The expression levels of enzymes related to cholesterol metabolism in 
the liver of Wistar rat fed diets of the control (□), ProtL (■), and ProtH (■) 
diets. Data are means ± SD (n = 7). Relative values are presented as the ratio of 
each mRNA to GAPDH mRNA. Values not sharing a common letter are significantly 
different at P<0.05. Data were analyzed by Tukey-Kramer test. The expression levels 
of  enzymes  related  to  cholesterol  metabolism  were  analyzed  by  the  real-time 
quantitative polymerase chain reaction method. CYP7A1, cholesterol 7α-hydroxylase;
HMGR,  3-hydroxy-3methylglutaryl-CoA  reductase;  LDL-R,  low  density  lipoprotein 
receptor; SR-B1, scavenger receptor class B type 1; ABCA1, ATP-binding cassette 
A1; ABCG5, ATP-binding cassette G5; ABCG8, ATP-binding cassette G8; GAPDH, 
glyceraldehyde-3-phosphate  dehydrogenase
oxidation in peroxisomes, was significantly higher in protamine 
fed rats than in the control group, and FAS activity, a key enzyme 
in fatty acid synthesis, was significantly higher in the ProtH 
group than in the control group. In contrast, there was no 
difference among the groups in the activity of ACC, another key 
enzyme in fatty acid synthesis. The activity of G6PDH, a key 
enzyme in the production of cellular NADPH, which is required 
for the biosynthesis of fatty acids and CHOL, was significantly 
lower in the ProtH group compared with the control group. The 
activity of PAP, a rate limiting enzyme for TG synthesis in the 
liver, showed no differences among the groups.
Fecal lipids and protein digestibility
We determined the fecal lipid and protein contents to examine 
the effect of dietary protamine on fecal lipid excretion and 
apparent protein digestibility (Table 7). The fecal fatty acid 
content, which is an index of fat absorption in the small intestine, 
was significantly higher in the ProtH group than in the control 
or ProtL groups. The fecal CHOL content was significantly 
higher in the ProtH group than in the control group, and those 
in the ProtL group tended to be higher than in the control group. 
The fecal bile acid content was significantly higher in rats fed 
protamine than in rats fed casein. Fecal dry weight, nitrogen 
content, and apparent protein digestibility were not different 
among the groups.
mRNA expression levels
We determined the mRNA expression levels of enzymes and 
receptors related to CHOL metabolism in the liver tissue to 
evaluate the effect of dietary protamine using real-time 
quantitative PCR (Fig. 1). The expression levels of CYP7A1, 
HMGR, LDLR, SR-B1, and ABCA1 were not different among 
the groups. In contrast, the expression levels of ABCG5 and 
ABCG8, which play major roles in the secretion of CHOL into 
bile, were higher in the ProtH group than in the control group, 
while those in the ProtL group tended to be higher than in the 
control group.
Discussion
Dietary therapy can be considered as the first choice treatment 
or at least as important as medical treatment. Dietary protein 
has been shown to affect lipid metabolism in humans and animals 
[26-28]. For example, it is known that soy protein relative to 
casein exerted hypocholesterolemic and hypotriglyceridemic 
effects in experimental animals [26-28]. In addition to this effect 
of plant protein, fish protein also seemed to influence blood lipid 
contents and stimulated fibrinolysis in experimental animals 
[8-10]. Protamine from salmon is rich in the basic amino acid Ryota Hosomi et al. 467
arginine, but there have been few studies on the beneficial health 
effects of protamine. Therefore, this study examined the effect 
of protamine from salmon on lipid metabolism in serum and the 
liver compared with the effect of casein.
In the present study, we demonstrated that dietary protamine 
significantly lowered the serum and liver TG contents compared 
with dietary casein. The reasons for the decrease in serum and 
liver TG contents were thought to be related to the absorption 
of lipid from the small intestine [13,29], and we analyzed the 
effect of dietary protamine on fat absorption by determining the 
total amount of fatty acids in feces. The fecal fatty acids content 
was higher in the ProtH group than in the control group. Tsujita 
et al. [13] suggested that a basic protein or protamine strongly 
inhibited the hydrolysis of trioleoylglycerol emulsified with 
phosphatidylcholine. Moreover, the basic peptide polylysine is 
a candidate agent for the inhibition of intestinal lipid absorption 
while resisting proteolysis [29]. Thus, we hypothesized that the 
inhibition of fat absorption by basic peptides produced during 
the digestion of protamine, which contains large amounts of 
arginine corresponding to about 68 mol% of its total amino acids. 
A previous study suggested that protamine reduced the plasma 
TG concentration through the inhibition of dietary fat absorption 
[14]. However, in the present study, daily lipid (TG) intake was 
about 8.5 g, and daily fatty acids intake was about 8.0 g when 
converting TG into fatty acids. The daily excretion of fecal fatty 
acids was 40.1 ± 6.5 mg and 87.8 ± 12.5 mg for the control and 
ProtH groups, respectively. Consequently, the apparent lipid 
digestibility was about 99.5% and 99.0% for the control and 
ProtH groups, respectively. Therefore, we speculated that the 
dietary protamine increased fecal fatty acid excretion but did not 
extremely decrease the serum and liver TG contents. 
Another reason considered for the decrease in serum and liver 
TG contents was the alteration of enzyme activity related to TG 
metabolism in the liver, and we examined the effect of dietary 
protamine on enzyme activity related to fatty acid β-oxidation 
and fatty acid synthesis. As shown in Table 6, CPT2 and ACO 
activities, which are key enzymes of fatty acid β-oxidation in 
mitochondria and peroxisomes, in the liver were higher in rats 
fed protamine than in rats fed casein. FAS activity, a rate limiting 
enzyme in fatty acid synthesis, was higher in rats fed protamine 
than in rats fed casein. Moreover, PAP activity, a key enzyme 
in the regulation of de novo TG synthesis, was not different 
among the groups. Therefore, we hypothesized that the decrease 
in liver TG content with the protamine-containing diets were 
attributed to the enhancement of fatty acid β-oxidation and not 
to the alteration of de novo TG synthesis. The increased FAS 
activity due to dietary protamine may be prevented by the 
enhancement of fatty acid β-oxidation.
In this study, the serum VLDL-TG and VLDL-C contents in 
rats fed protamine were significantly lower than in rats fed casein. 
VLDL, which is a TG-rich lipoprotein, is assembled and stored 
in the liver by microsomal triglyceride transfer protein and 
apolipoprotein B. In addition, VLDL hydrolyzes TG to fatty acid 
and monoacylglycerol by the action of lipoprotein lipase in a 
number of peripheral tissues, including adipose tissue, skeletal 
and cardiac muscle, and the mammary gland [30]. Further studies 
are necessary to clarify the effect of dietary protamine on 
lipoprotein metabolism of VLDL hydrolysis, assembly, and 
secretion in peripheral tissue and the liver.
Another interesting result was the effect of protamine on 
CHOL metabolism. The serum CHOL and LDL-C contents were 
significantly decreased in the ProtH group compared with the 
control group. In addition, the liver CHOL contents in rats fed 
protamine were significantly lower than in rats fed casein (Table 
5). Nagata et al. [28] found that the degree of serum CHOL 
lowering depended on the extent fecal steroid excretion. In the 
present study, the fecal excretion of CHOL and bile acid were 
higher in rats fed protamine than in rats fed casein (Table 7). 
Higaki et al. [27] suggested that feeding soy protein stimulated 
the fecal excretion of bile acid and demonstrated that the increase 
in fecal bile acid was accompanied by an increase in fecal 
nitrogen excretion. The fecal excretion of bile acid suggested 
that hydrophobic peptides were produced by intestinal digestion 
of protein bound bile acid by hydrophobic interaction [31]. 
Moreover, Kayashita et al. [32] reported that a dietary buckwheat 
protein product had lower plasma CHOL content and enhanced 
excretion of fecal CHOL and nitrogen compared with rats fed 
casein, and there was a significant correlation between fecal 
CHOL and nitrogen. Thus, dietary proteins such as soy and 
buckwheat protein increased the fecal excretion of steroids 
concomitant with increased fecal nitrogen due to its low 
digestibility. However, dietary protamine increased the fecal 
excretion of CHOL and bile acid, although there was no influence 
on the fecal excretion of nitrogen. This result indicated the 
possible effect of dietary protamine on the fecal excretion of 
CHOL and bile acid by a new mechanism. The mechanism of 
fecal CHOL and bile acid excretion in rats fed protamine is not 
clear at present, and further experiments will be necessary to 
clarify this mechanism and the effects on the binding capacities 
of bile acid and the micellar solubility of CHOL and bile acid.
It is well known that serum and liver CHOL levels are 
maintained by a balance between CHOL biosynthesis and 
catabolism in the liver, uptake into the liver, and secretion and 
excretion from the liver. The decreased liver CHOL content 
found in rats fed protamine could be expected to arise from a 
decrease in CHOL synthesis, an increase in CHOL catabolism 
to bile acid, an increase in CHOL efflux, or a decrease in CHOL 
uptake. Therefore, we evaluate the mRNA expression levels of 
enzymes and receptors related to CHOL metabolism in the liver 
using quantitative real-time PCR. CYP7A1, a rate limiting 
enzyme of bile acid synthesis, HMGR, a rate limiting enzyme 
of CHOL synthesis, and LDLR and SR-B1, uptake serum 
lipoproteins, showed differences in rats fed protamine compared 
with in rats fed casein (Fig. 1). The CHOL lowering effect of 
dietary protamine was not attributable to the decrease in CHOL 
biosynthesis, catabolism, or uptake.468 Effect of protamine on rat lipid metabolism
Much attention has been focused on the finding that control 
of the delivery and disposal of CHOL are regulated by membrane 
transporters of the ATP-binding cassette
  (ABC) superfamily [33]. 
We analyzed the liver mRNA expression levels of ABCA1, a 
transporter involved in the production of HDL, ABCG5 and 
ABCG8, which form heterodimers and play a major role in the 
secretion of CHOL into bile. The expression levels of ABCA1 
were not different among the groups. Surprisingly, dietary 
protamine increased the expression levels of ABCG5 and ABCG8 
in the liver. This results in decreased liver CHOL through the 
enhancement of the secretion of CHOL into bile. In addition, 
the increased expression levels of ABCG5 and ABCG8 also 
influenced the excretion of fecal CHOL. Hence, we suspected 
that the hypocholesterolemic effect of dietary protamine was 
attributable to the enhanced excretion of fecal CHOL and bile 
acid and the secretion of CHOL into bile.
These results showed that dietary protamine enhanced β
-oxidation activities and the expression levels of ABCG5 and 
ABCG8 in the liver. We predicted that the alteration in lipid 
metabolism in rats fed on the protamine diet were possibly due 
to arginine, a large amount of which is present in protamine. 
Dietary L-arginine produces nitric oxide (NO) with NO synthase 
in virtually all mammalian cells and plays an important role in 
lipid metabolism [34]. Future studies are necessary to test this 
hypothesis.
This study showed that dietary salmon protamine, compared 
with dietary casein, had a TG lowering effect in serum and the 
liver, which at least in part arose by the enhancement of β
-oxidation in the liver. The decrease in serum CHOL, LDL-C, 
and liver CHOL contents in rats fed protamine were suggested 
to be related to the enhancement of fecal excretion of CHOL 
and bile acid and the increased liver mRNA expression levels 
of ABCG5 and ABCG. In view of the fecal nitrogen results 
(Table 7), we suspected that the enhanced fecal excretion of 
CHOL and bile acid were possibly by a different mechanism 
from the effect of dietary soy protein. The observed reductions 
in serum TG, CHOL, and LDL-C and liver TG and CHOL in 
rats fed protamine suggested possible beneficial effects on the 
development and prevention lifestyle-related diseases, such as 
hyperlipidemia and atherosclerosis.
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